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1. Introduction
 The WHC Strategic Plan for 2007-2009 identified the area of ‘Young Women and Alcohol’ as 
a topic for further investigation by the Council. The aim in the Strategic Plan was “to research 
the role of alcohol in the life of young women and its effect on their physical and mental 
health”. After an initial examination of the area, however, the topic was expanded to cover 
drug misuse as well as alcohol, as it became clear that heavy consumption of alcohol is often 
linked to drug use, and not just among young women. A decision was therefore taken to 
produce a suite of papers on ‘Women and Substance Misuse’ to ensure that all the relevant 
issues would be included. 
The purpose of the papers is to explore women’s alcohol and drug misuse, focusing on 
gender differences and highlighting in particular the effects substance misuse has on 
women’s health. The aim of the present paper is to provide an overview of the topics of most 
concern regarding women and substance misuse. The Women’s Health Council envisages 
that the papers will be of interest to policy and strategy makers, as well as health service 
providers and those with an interest in women’s health.
 1.1. Gender differences in substance misuse
 
At a societal level, substance misuse is a male dominated area. Men are more likely than 
women to drink heavily and to misuse drugs. Lifetime abstinence is more common among 
women than men, with 23% of women ‘never drinking’ alcohol in the previous 12 months, 
compared to 15% of men (Morgan et al., 2008), whereas 29% of men report lifetime use of 
any illegal drugs compared to 19% of women (NACD & DAIRU, 2008). The ‘typical’ problem 
drug user profiled in the research is young and male (Reynolds et al., 2008).
 A detailed look at the issue reveals a more complicated picture, however, in which patterns 
in the prevalence of substance use and related health and social consequences differ greatly 
between the sexes. The most recent population survey of alcohol use in Ireland found that 
women’s lifetime use of alcohol increased in three1 of the ten Regional Drugs Task Forces 
(RDTF) areas (NACD & PHIRB, 2008). In addition, recent research has shown that while men 
are more likely to misuse illegal drugs, women predominate in the misuse of prescription 
drugs such as tranquillisers and anti-depressants (NACD & PHIRB, 2009). Changing patterns 
among young people also suggest that substance misuse may be becoming a larger 
problem for women than it has been traditionally. 
1  Midland, North Eastern and North Western RDTFs 
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 1.2. The narrowing gender gap 
 
While it is still the case that more men than women misuse drugs and alcohol in Ireland, 
concerns have been raised by recent research that shows a narrowing in the traditional 
gender gap among young people. Recent Irish research carried out for the European School 
Survey Project on Alcohol and Other Drugs (ESPAD) found that girls are now drinking 
almost as often as boys, and more girls (29%) than boys (25%) reported being drunk during 
the previous month (Morgan & Brand, 2009). In addition, slightly more girls (44%) than 
boys (42%) reported binge drinking during the previous month. Other Irish research has 
found that an equal proportion of 15-16 year old boys and girls reported ever having used 
cannabis, a slightly larger ratio of 15-16 year old girls than boys have repeatedly used ecstasy, 
and male and female teenagers are now equally at risk of opiate misuse (EMCDDA, 2006, 
Fagan et al., 2008). These figures obviously give rise to concerns about the future health and 
well-being of the women in these cohorts, and may suggest that drug and alcohol issues will 
be a greater cause of morbidity and mortality for women in the future. 
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2.1. Family
 
 Research has shown that a woman’s family background is an important influence on 
substance misuse, in two main ways. In the first instance, the behaviour of other family 
members can influence a woman’s own behaviour, so that research has shown that having a 
family background of heavy drinking or drug misuse can increase the likelihood of a woman 
having problems with substance misuse herself (National Institute on Alcohol Abuse and 
Alcoholism, 1990, Corrigan & Butler, 1991, Institute of Alcohol Studies, 2008, Farrell, 2001). 
Secondly, lack of cohesive and supportive family life is a significant predisposing factor to 
substance misuse among women, and it has been suggested that girls are more responsive 
than boys to parental influences on substance use. American research has found that the 
worse a girl’s relationship with her parents, the earlier she will begin drinking alcohol and 
the greater her likelihood of misusing drugs (The National Center on Addiction & Substance 
Abuse at Colombia University, 2006), while Irish research found that parental disapproval 
and ‘bonding’ to family, particularly to parents, tend to act as restraining factors in substance 
use (Grube & Morgan, 1990). The latest ESPAD report for Ireland found that while emotional 
support and care from parents influences children’s substance (mis)use, parental monitoring, 
where children felt that their parents were ‘keeping an eye’ on their activities, was more 
important still (Morgan & Brand, 2009). It is therefore essential that parents are educated and 
aware about the issues involved and about the particularly important role they can play in 
influencing their daughters’ behaviour in this regard. 
2.2. History of abuse
 
Research has shown that a large proportion of women with substance use problems are 
victims of domestic violence, incest, rape, sexual assault and child physical abuse (Cormier 
et al., 2004, Roberts & Vromen, 2005, Woods, 1999, UNODC, 2004, Wilsnack et al., 1997). 
The National Center on Addiction & Substance Abuse at Colombia University has found 
that girls who report having experienced physical or sexual abuse are twice as likely to 
smoke, drink or use drugs as those who were not abused (National Center on Addiction & 
Substance Abuse, 2006, National Center on Addiction & Substance Abuse, 2003). Physical 
abuse during adulthood has also been associated with problematic use of alcohol among 
women (National Institute on Alcohol Abuse and Alcoholism, 1999). One explanation for 
the higher levels of substance use among women who have been abused is that drugs and 
alcohol may be used as a way of coping with the pain, both physical and mental, of such 
experiences (Poole & Dell, 2005, National Center on Addiction & Substance Abuse, 2006, 
Roberts & Vromen, 2005, TSA Consultancy, 2005). Treatment services for women who  
misuse drugs or alcohol must be aware of these findings so that services are provided in 
a sensitive manner, with female staff and integrated care that will take all of the woman’s 
needs into account.
2. Substance misuse: 
Significant influencing factors 
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3.1. Physical health 
 
Women appear to be more vulnerable than men to the adverse effects of alcohol and drug 
misuse on physical health. Women have been found to develop alcohol-related health 
problems earlier in their drinking careers than men (Mongan et al., 2007), and may also 
progress to problematic drug use and dependency more quickly than men (Cox et al., 2008). 
Women develop alcohol-related liver disease, such as cirrhosis or hepatitis, after a shorter 
period of time and after lower levels of drinking than men, and they are more likely to die 
from these conditions than are men (Institute of Alcohol Studies, 2008, Poole & Dell, 2005, 
National Institute on Alcohol Abuse and Alcoholism, 1999). Female drug users are more likely 
than their male counterparts to report a range of physical and mental health complaints, 
in spite of their shorter histories of drug use and shorter injecting careers (Cox & Lawless, 
2000). Women’s biological make-up is partly responsible for the negative effects on their 
health; since women have a proportionally higher ratio of fat to water than men they are 
less able to dilute alcohol or other substances within the body, and will therefore have a 
higher concentrations in their blood than men after taking in the same amounts (Institute of 
Alcohol Studies, 2008). Women’s hormones also affect how much and how quickly alcohol 
or drugs are absorbed. A woman’s drinking or drug use may also leave her more vulnerable 
to violence/attack by others (Poole & Dell, 2005, EMCDDA, 2008, Institute of Alcohol Studies, 
2008)2. Women should be aware of the increased risks to their health posed by alcohol and 
drug misuse, and education on the hazards of substance misuse provided to young people 
should highlight women’s vulnerability in this regard. 
3.2. Mental health 
 
Strong links have been found between substance misuse and depression, and it has been 
suggested that depression may be a reason for, as well as a product of, substance misuse 
(Needham, 2007). Women in the general population are twice as likely as men to suffer 
from depression (Women’s Health Council, 2005), and it may therefore be an important 
pathway to substance misuse for them, as well as being a significant consequence. High 
rates of depression have been found among substance misusers, and alcohol and drug 
use have been linked with higher rates of suicide. Particularly high rates of depression have 
been found among drug users, who are at greater risk of suicide than those who do not 
misuse drugs (Lyons et al., 2008). This risk may be heightened among women, as research 
has shown that women (80%) are more likely than men (65%) to overdose on drugs as a 
method of deliberate self-harm (National Suicide Research Foundation, 2008). By its very 
nature, alcohol is a depressant and it can facilitate suicide by increasing impulsivity, changing 
mood and deepening depression (Hope, 2008). In 2006-2007 there was evidence of alcohol 
consumption in 38% of female episodes of deliberate self-harm, and the numbers of people 
3. Effects on health
2   It is crucial to note, however, that while substance misuse can increase a woman’s vulnerability, this should not deflect 
attention or blame from the perpetrator, suggest that the perpetrator’s responsibility for the assault is reduced in any way,  
or suggest that the woman is somehow to blame for the attack.
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presenting in hospitals with deliberate self-harm generally peak at times coinciding with 
the times when people traditionally consume higher amounts of alcohol - in the hours 
around midnight, with one-third of all presentations occurring on Sundays and Mondays 
(National Suicide Research Foundation, 2008). Women’s mental health may also suffer 
disproportionately as women often experience more stigma due to substance misuse than 
their male counterparts. There is still a double standard that judges women’s substance 
misuse more harshly than men’s, particularly if the woman has children. This greater stigma 
can result in greater guilt and shame for women and for their families, and may lead to 
women being reluctant to seek treatment (Wilsnack & Wilsnack, 2002). 
The Women’s Health Council
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As the Women’s Health Council pointed out in Promoting women’s health; A population 
investment for Ireland’s future, although more women are now taking part in the paid labour 
force, women are still primarily responsible for providing care to the members of their 
families and others in their communities (Women’s Health Council, 2002). The implication 
of this finding is twofold; first, that it is women who assume responsibility for the care and 
management of substance misusers in the family, and secondly, that where women’s own 
substance misuse is the issue, women may not be present to play this key role in supporting 
and caring for the family. 
 When there is a need to find alternative care arrangements or support for a woman 
drug user or her children, it is other women within the kinship system –mothers, sisters, 
grandmothers and aunts – who are called upon (Woods, 1999). The same holds true for male 
drug users; the vast majority of those interviewed for NACD’s research on the experiences 
of families seeking support in coping with heroin use were drug users’ mothers (Duggan, 
2007). Thus when the Government noted in the National Drugs Strategy 2001-2008 that the 
families of problem drug users ‘have the potential to be key to the rehabilitative effort’, and 
are ‘a valuable resource in terms of childcare’ (Department of Community Rural and Gaeltacht 
Affairs, 2007), the gender dimension of these policy statements should be highlighted. In 
practice, it is usually the drug user’s mother, sister, aunt, grandmother, wife or girlfriend who 
will provide this care and support, in most cases at some cost to her own health and well-
being. One of the risks to a woman’s health in this situation is the risk of violent and abusive 
behaviours from substance misusers; research has found, for example, that women have a 
higher chance of being harmed by others who are drinking (Poole & Dell, 2005). Women 
may also have to assume sole financial responsibility for the family if their partner is misusing 
drugs or alcohol. The negative implications for the physical and mental health of women in 
these situations are clear. 
 Where a woman’s own substance misuse is the issue, those around her, particularly her 
children and family, will be affected. Children are particularly at risk as female substance 
misusers are more often responsible for children than their male counterparts (Poole & Dell, 
2005, EMCDDA, 2005, EMCDDA, 2006, Painter et al., 2000, Cox et al., 2008, Woods, 1999), and 
are more likely to be lone parents (Farrell, 2001). Research has found that the children of 
mothers with substance misuse problems are less likely to remain with their birth mother, 
more likely to show developmental delay, and are significantly more at risk of abuse and 
neglect than the general population (Keen et al., 2000). As a group, the children of drug 
misusing parents perform less well academically and socially (Keen & Alison, 2001). Parental 
misuse of drugs can also be an important influence on children’s behaviour around drugs. As 
mentioned above, children have been found to be more likely to misuse drugs in situations 
where their parents misuse drugs, where there is prolonged or traumatic parental absence, 
failure to communicate on an emotional level, and chaotic or disturbed family members 
(UNODC, 1995).
4. Effects on society
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5.1. Pregnancy
 
 Use of alcohol or drugs during pregnancy has been linked with a range of serious health 
and developmental consequences for the foetus. High intakes of alcohol have been strongly 
associated with an increased risk of miscarriage, particularly in the first trimester, congenital 
birth defects (teratogenesis), and a range of Foetal Alcohol Spectrum Disorders (FASD), 
(Poole & Dell, 2005, Homan et al., 2007, Whittaker, 2003, Royal College of Obstetricians 
& Gynaecologists, 2006, Guerrini et al., 2009). Misuse of drugs in pregnancy has been 
associated with increased rates of low birth weight, pre-term delivery, Sudden Infant Death 
Syndrome (SIDS), intrauterine growth restriction (IUGR), underdevelopment of organs and/or 
limbs, miscarriage and stillbirth, and Neonatal Abstinence Syndrome (NAS) (Whittaker, 2003). 
The chaotic lifestyle associated with substance misuse can also mean that women do not 
access maternity care as soon as is recommended, and that they do not attend antenatal 
care as often as non-drug using women. It is therefore essential to ensure that when 
pregnant substance users do come into contact with services, they can access specialised, 
integrated care that will take all of their needs into account. This is also important as many 
of the obstetric problems associated with substance misuse, including low birth weight 
and increased perinatal mortality, are also associated with social deprivation, poor antenatal 
care, and poor maternal health and nutrition (Mounteney, 1999). The Drug Liaison Midwife 
service was found to help lessen the stigma for drug-misusing women, and improved the 
relationships between the women and the obstetric and drug services (Scully et al., 2004, 
Scully et al., 2001). However, the services provided to pregnant drug misusers often do not 
continue beyond the birth, effectively leaving such women, who may be in a heightened 
state of vulnerability after the birth, and their babies without specialist support (Keen & 
Alison, 2001). Services to drug misusing mothers need to be continued beyond birth to 
ensure the best possible outcome for both the mother and her child(ren). Pregnancy is often 
a time of new beginnings for women with alcohol and/or drug misuse issues, and a prompt 
that encourages them to tackle their substance use (Guerrini et al., 2009). Harm reduction 
approaches, which do not judge women but educate them about the effects of drug and 
alcohol use during pregnancy, and offer supportive encouragement to reduce their use 
of drugs and/or alcohol, may therefore present the best method for securing a healthy 
outcome for both the woman and her baby. 
5.2. Binge drinking
 
 Ireland has the highest level of binge drinking, defined as having six or more standard drinks3 
in one sitting, in Europe (HSE, 2008). Responding to the SLAN study, 17% of women and 
38% of men reported consuming six or more drinks on one occasion at least once a week 
(Morgan et al., 2008), and European research found that only 7% of men and 16% of women 
5. Areas of particular concern for women
3   One standard drink is the equivalent of half a pint of beer, a small glass of wine or a single measure of spirits. It contains 10g  
of pure alcohol (HSE, 2008b). 
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said they had never drunk five or more drinks on one occasion (European Commission, 
2007). The Health Research Board has expressed particular concern about the consequences 
of alcohol use among young women (aged under 17 years), as alcohol-related hospital 
discharge figures for this group are proportionally much higher than for other groups of 
women (Mongan et al., 2007). Certainly, research has shown that binge drinking appears to 
be most common among young people. For women, the SLÁN study found that those in 
the youngest age group (18-29 years) were the most likely to consume six or more drinks 
on one occasion at least once a week (Morgan et al., 2008), and the most recent ESPAD 
report commented on the narrowing gender gap in binge drinking among Irish school age 
children, with 42% of boys and 44% of girls reporting binge-drinking during the previous 
month (Morgan & Brand, 2009). Such findings may be indicative of a trend for increased 
alcohol-related morbidity among middle-aged women in the future (Mongan et al., 2007).
5.3. Prescription drug misuse  
 
Although men outnumber women where the misuse of most illicit drugs are concerned, 
women have been found to predominate in the misuse of prescription drugs. Research 
carried out by the Women’s Health Council found that women were more likely than men to 
be taking prescription medicine, and that women in least well off socio-economic groups 
were the most likely to be taking prescription medication (Women’s Health Council, 2008). 
Confirming these findings, the National Advisory Committee on Drugs has found that 
women in Ireland report higher prevalence rates for lifetime use of sedatives or tranquillisers 
than men (13% compared to 8%), and also anti-depressants (13% compared to 6%) (NACD 
& DAIRU, 2008, NACD & PHIRB, 2009). The higher rate at which women are prescribed 
tranquillisers, sedatives and anti-depressants when compared to men is a serious cause 
for concern. Women’s higher use of benzodiazepines has already been highlighted by Irish 
research. The Department of Health & Children’s Benzodiazepine Committee found higher 
usage amongst females of all age groups (Department of Health & Children, 2002), and 
research has further shown that women are twice as likely as men to have benzodiazepines 
prescribed to them for ‘non-clinical’ symptoms such as stress, grief, acute or chronic illness, 
physical pain or adjustment to a major life change and to have them prescribed for longer 
periods (Cormier et al., 2004, Ballymun Youth Action Project, 2004, Poole & Dell, 2005). 
Although only small numbers of individuals currently present for treatment for problem 
benzodiazepine or other prescription drug use, the HRB has recommended that the impact 
of these drugs be addressed within treatment and prevention services (Lyons et al., 2008). 
Given the higher prevalence rates among women, it is essential that such treatment services 
pay particular attention to women’s needs and that women are targeted by any health 
promotion or prevention campaigns undertaken in this regard. In addition, in order to  
fully address the circumstances of drug misuse among women, it is essential that the  
misuse of prescription drugs is included in policy/strategy, and that prescribing patterns are 
also examined. 
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 5.4. Polysubstance use 
 
Polysubstance use is an issue of growing concern in Ireland. Figures collected in the 2002/3 
population survey by the NACD showed that the phenomenon, which most commonly 
involves combining the use of alcohol, tobacco and any illegal drug, appears to be rising. 
At that point polysubstance use was more common among men (2.65%) than women 
(1.2%); results have not yet been published for the 2006/7 survey (NACD & DAIRU, 2007). The 
majority of deaths directly due to drugs on the HRB’s National Drug Related Deaths Index 
(NDRDI) showed polysubstance use, and the majority of people entering treatment for the 
first time between 2001 and 2006 reported problem use of more than one drug (Reynolds 
et al., 2008, Lyons et al., 2008). Overall, of the new treatment cases between 2001 and 2006, 
31% reported use of two substances, 23% reported using three substances simultaneously 
and 18% reported problem use of four or more substances (Reynolds et al., 2008). Of those 
treated for problem alcohol use between 2004 and 2006, 21% reported polysubstance use, 
the most commonly misused drugs being cannabis (16%), cocaine (7%), ecstasy (7%) and 
amphetamines (2%) (Fanagan et al., 2008). 
 Polysubstance use makes treatment more complex and is often associated with poorer 
outcomes. Commentators have therefore emphasised the need for treatment services 
that work in an integrated and flexible manner to manage all of the substance user’s 
needs, addressing both alcohol and drug use at the same time. The importance of services 
integrating treatment for polysubstance use has been illustrated by the results of the ROSIE 
study. The researchers highlighted the fact that alcohol increases the risk of overdose when 
used with sedative drugs including methadone, and that the threshold for fatal methadone 
overdose is lowered by alcohol, especially for women. As the study found that women had 
higher levels of alcohol use than men at one-year follow up, and that they were also more 
likely than men to be in methadone treatment, the researchers concluded that their results 
demonstrated the need for treatment services, especially those providing methadone, to 
continuously assess and actively target drinking behaviour (Cox et al., 2008). These findings 
also suggest that the integration of drug and alcohol treatment services, as well as that 
of policy and strategy, may be especially important for women. In this regard, the WHC 
supports the recent decision by Government to integrate alcohol and drug misuse in a 
single policy/strategy on substance misuse.
The Women’s Health Council
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 6.1. Services in Ireland 
 
For the most part, services in Ireland providing treatment for substance use deal with both 
alcohol and drug misuse (Health Promotion Unit, 2006). This is particularly the case in areas 
outside Dublin (Carew et al., 2009) where services are more likely to be integrated; within 
Dublin services are slightly more fragmented with a small proportion of services offering 
treatment for alcohol alone, drug misuse alone or a few organisations offering treatment 
services for alcohol and prescription drug misuse. Services are available in a range of private 
and public settings, including general and psychiatric hospitals, community-based services 
and residential centres. Public clinics usually have no charge and are based in community 
health centres or local health offices, with addiction counselling offered in many day 
hospitals. Community care services offer therapy for families, couples and groups, as well 
as the individuals affected. Private treatment services, run by charities and private limited 
companies, generally have their own premises and charge for their services, but costs for 
some are covered by the GMS, social welfare payments or private health insurance. Referrals 
to most programmes can come from a doctor, social worker, the courts and probation 
services, community nurses or workplaces, although some are open access and some offer 
places conditional on an initial assessment or interview. 
 There is wide variation in the numbers and types of treatment services across the country. 
A directory of drug and alcohol services published by the Health Promotion Unit in 2006 
showed that Dublin has the greatest concentration of services, as might be expected given 
its greater population density, with forty-two services listed not including HSE satellite clinics. 
In comparison, there were no dedicated services available in Leitrim (clients had to travel 
to Sligo town), Offaly (travel to Port Laoise) or Cavan (travel to Monaghan or Sligo) (Health 
Promotion Unit, 2006).
 For the future, the HSE Working Group on Residential Treatment & Rehabilitation (Corrigan 
& O’Gorman, 2007) has endorsed a four tier model of care for alcohol and drug treatment 
services. The model envisages a range of services at varying levels of intensity from drug 
information and education services provided in general health care settings, to intensive 
interventions for people with severe problems provided through day or inpatient  
hospitals and including residential specialised drug treatment in dedicated inpatient or 
residential units.
6. Treatment  
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6.2. Needs of women 
 
 At present, women are more likely to receive treatment for substance misuse in non-
residential or GP settings in Ireland (O’Brien & Dillon, 2001), whereas more men avail of 
residential or low-threshold services. Women may have a preference for treatment in  
non-residential settings due to their childcare responsibilities, discussed above.  
Residential treatment services in Ireland are generally more focused towards men  
(Corrigan & O’Gorman, 2007) however; currently there is only one residential treatment 
centre in Ireland that incorporates childcare facilities, Ashleigh House, run by the Coolmine 
Therapeutic Community.
 6.2.1. Childcare 
Being responsible for children can mean that it is difficult for women to attend for treatment 
(UNODC, 2004). Studies in Ireland have found that while parents (mostly women) often 
wanted to take active steps to address their drug use, they were unable to do so as they 
did not have access to regular childminding arrangements (Moran, 1999, Butler & Woods, 
1992). Women may also be reluctant to attend for treatment as they fear that their substance 
misuse may cause them to be labelled ‘unfit mothers’ and that their children will be taken 
into care as a result (Butler & Woods, 1992, Farrell, 2001, Bell & Harvey-Dodds, 2008, Painter 
et al., 2000, Hedrich, 2000, UNODC, 2004). It is therefore extremely important that treatment 
services are made accessible to women by taking their childcare needs into account. Crèche 
facilities encourage women to attend for treatment by providing for women’s practical 
childcare needs, but also by signalling the service’s acceptance of women’s situations (Moran, 
1999). Both drop-in and full-day crèches are needed so that women can participate in all 
types of treatment (including more intensive treatment and rehabilitation) and to facilitate 
access to training and employment opportunities (Moran, 1999, Woods, 1999). 
 Action 54 of the National Drugs Strategy called on the Health Service Executive to consider, 
as a matter of priority, how best to integrate childcare facilities with treatment and 
rehabilitation centres and how childcare can best be provided in a residential treatment 
setting (Department of Tourism Sport & Recreation, 2001). In addition, the Working Group 
on Drugs Rehabilitation identified the lack of childcare services as a significant barrier 
to accessing treatment for women and reported that drugs-related services, including 
residential services, should have access to an appropriate level of childcare services and 
facilities. It therefore recommended that the HSE, in conjunction with the Office of the 
Minister for Children, should decide on how best to integrate childcare facilities with 
treatment and rehabilitation services and subsequently progress the matter (Department 
of Community Rural and Gaeltacht Affairs, 2007). The report of the HSE Working Group 
on Residential Treatment & Rehabilitation did not refer to providing childcare as part of 
rehabilitation services; it recommended the investigation of “innovative approaches such 
as providing the necessary supports so that family members can act as short-term foster 
parents” (Corrigan & O’Gorman, 2007). 
The Women’s Health Council
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 6.2.2. Gendered approach to treatment 
Since women and men can have quite different experiences and issues around substance 
misuse, a gendered approach to treatment and service provision must be adopted so that 
women’s and men’s needs are dealt with in the most appropriate manner possible. As 
emotional and relational reasons are often at the crux of women’s misuse of drugs and/or 
alcohol, services for women may require an increased emphasis on care and support (Poole 
& Dell, 2005, National Center on Addiction & Substance Abuse, 2003). In this regard, support 
groups and one-to-one counselling have been suggested as methods of encouraging 
women to attend treatment services (Farrell, 2001, EMCDDA, 2006). It is also essential that 
staff are aware of the particular pathways and background factors that lead to women 
misusing drugs and/or alcohol so that their needs can be fully addressed. 
 6.2.3. Integrated, holistic treatment services 
An important issue that has been identified regarding treatment services for women is the 
fragmented nature of service provision. The need for integrated services during pregnancy 
has been mentioned above, but this holds true for all substance-misusing women. Research 
on the needs of women in prison concluded that, in order to prevent women being lost 
through loopholes in the system, there is a need for greater co-operation, collaboration and 
communication between agencies providing services (Comiskey et al., 2006). Treatment 
programmes often do not provide women who misuse drugs and/or alcohol with the full 
array of services they may need, including prenatal and gynecological care, contraceptive 
counselling, childcare, job training, advice and support around housing, and counselling 
for sexual and physical abuse. Given the chaotic nature of the lives of those with substance 
misuse issues, and the problems this creates around connecting with services, it is important 
that services are co-ordinated to avoid presenting women with a confusing array of 
appointments and services and losing them from the system entirely (Keen & Alison, 2001). 
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In putting together the papers on substance misuse, the Women’s Health Council aimed to 
explore women’s alcohol and drug misuse, focusing on gender differences and highlighting 
the effects substance misuse has on women’s health. It is clear from the research that 
substance misuse is an issue for women, albeit in different ways compared to men. Although 
more men than women misuse drugs and alcohol in Ireland, the gender gap may be 
closing for younger women. Recent research has shown that girls are now drinking almost 
as often as boys, with binge drinking being slightly more common among girls, and that 
girls and boys are now equally likely to misuse opiates and cannabis. Overall, however, 
women have different patterns of substance misuse than men - of particular note here is 
the concentration of women among misusers of prescription drugs. Women’s pathways into 
substance misuse are also distinct from those of men, and their social circumstances appear 
to be particularly disadvantaged when compared to those of their male counterparts. 
 7.1. Increased risk to women’s health 
 
Substance misuse causes both health and social problems, including chronic ill health, 
mental health difficulties, and relationship problems, as well as indirect effects on those close 
to the user. Although women are generally less likely than men to misuse drugs, women 
have been found to be particularly vulnerable to the negative health effects of substance 
drug use, even at the generally lower levels which they engage in compared to their male 
counterparts. Women have been found to develop alcohol-related health problems earlier in 
their drinking careers than men, and to progress to problematic drug use and dependency 
more quickly than men. Women’s biological make-up is partly responsible, particularly their 
proportionally higher ratio of fat to water than men, and their hormones, both of which 
affect how much and how quickly alcohol and drugs are absorbed. It is essential that women 
are aware of the increased risks to their health posed by alcohol and drug misuse, and 
education initiatives should highlight women’s vulnerability in this regard. 
7.2. Taking gender into account 
 
 7.2.1. Policy/Strategy 
It is clear that substance misuse affects women and men in distinct ways. In order to provide 
the most effective response possible, a gender analysis must be built into any new drug 
and/or alcohol policy in order to address the differences in patterns, types and pathways into 
substance misuse. 
7. Conclusions
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 7.2.2. Services 
This gender analysis must be carried through to substance misuse service development and 
delivery. Services for women may require an increased emphasis on care and support, and 
it is essential that staff are aware of the influences and background factors that can lead to 
substance misuse among women. In order to prevent women being lost through loopholes 
in the system, there is a need for greater co-operation, collaboration and communication 
between agencies providing services. 
 Caring for children is a central issue for women who wish to access substance misuse 
treatment services. The provision of childcare facilities in conjunction with treatment  
services can encourage women to attend by signalling acceptance of women’s situations, 
as well as responding to childcare needs in a practical way. It is extremely important that 
substance misuse services, including residential services, should also provide childcare 
services and facilities. 
7.3. Women & Substance misuse: Areas for further research
 
In conducting the present work on women and substance misuse, the Women’s Health 
Council has identified a number of areas of particular concern that warrant further attention. 
7.3.1. Polysubstance use
Polysubstance use, most commonly combining the use of alcohol, tobacco and any illegal 
drug, is an issue of growing concern in Ireland. It can make treatment more complex and 
is often associated with poorer outcomes. For these reasons, it is important that treatment 
services work in an integrated and flexible manner to manage all of the substance user’s 
needs, addressing both alcohol and drug use at the same time. The Women’s Health Council 
therefore supports the recent decision by Government to integrate alcohol and drug misuse 
in a single policy/strategy on substance misuse.
7.3.2. Binge drinking
Ireland has been found to have the highest level of binge drinking in Europe. Patterns of 
drinking and Ireland’s alcohol culture must be altered if the problems we experience in the 
area are to be resolved. In this regard, it would be useful to examine the reasons for over-
consumption as well as the consequences of binge drinking on the physical, mental and 
social well-being of women. Alcohol-related hospital discharge figures for women aged 
under 17 are proportionally much higher than for other groups of women, and women 
in the 18-29 year age group are the most likely to binge drink. Such figures represent a 
departure from the traditional model of drinking which should be investigated.
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7.3.2. Prescription drug misuse
Given the higher rate at which women both use and are prescribed tranquillisers or sedatives 
and anti-depressants, it is essential that women are fully informed about the properties of 
the drugs and their potential negative effects. It would be useful to carry out more research 
on the misuse of prescription drugs; although the NACD has recently published data on the 
prevalence of tranquilliser/sedative/anti-depressant use in Ireland, such figures should be set 
in the context of women’s lives. Prescribing patterns for these drugs should also be examined 
in more detail. 
Taken together, the Women’s Health Council hopes that these papers will provide a picture 
of women’s drug and alcohol misuse which will be of use to policy and strategy makers, 
as well as health service providers and those with an interest in women’s health. Although 
not as significant for women in the past as it has been for men, substance misuse is now a 
growing area of health risk for women, and one that may be a significant cause of mortality 
and morbidity among women in the future.
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